Aaron Wong, Jo Sims, Carol Slight
To Pro?le the demographics, complicationsand visual outcomes of patients presenting withUveitis in Auckland, New Zealand.
In total, 1,264 patients presenting to Uveitisclinics in a tertiary referrals centre between January2008 to April 2014 were analysed . Retrospectiveanalysis was used to collect data on patient demo-graphics as well as disease characteristics. Most recentvisual acuity was collected on all patients.
We found in our cohort that 14.9% ofpatients had a degree of visual impairment (visualacuity worse than 6/15 in at least one eye). Only 4patients (0.3%) had visual acuities worse than 6/60 inboth eyes. Rates of visual impairment were notablyhigher in the Maori (21.4%) and Paci?c Island(16.9%) ethnic groups as well as patients over the ageof 60 (24.3%). Visual impairment was more commonin patients with Posterior Uveitis (34.9%) andPanuveitis (31.6%) compared to Anterior Uveitis(9.5%). Almost half patients who developed either aMacular scar (45.1%), Retinal detachment (45.8%) ora Vascular occlusion (46.2%) had a degree of visual impairment.
In our population the prevalence ofvisual impairment in patients with Uveitis is similar toother international studies and the prevalence ofblindness (vision worse than 6/60 in both eyes) is low.Patients of Maori or Paci?c Island ethnicity, aged over60 or with Posterior or Panuveitis had increased ratesof visual impairment. The development of a Macularscar/ERM, Retinal detachment or Vascular occlusionsare likely to be associated with a poor visual outcome.
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY